Is serum neutrophil gelatinase-associated lipocalin a useful marker in acute pancreatitis?

Published: 30 July 2019
Author(s): David Ojalvo, Emrah Erkan Mazi, Mine Kara, Fatih Borlu
Issue: July 2019
Section: Letter to the Editor

Acute pancreatitis (AP) is the reversible inflammation of pancreas. Annually from 4.9 to 35 cases per 100,000 of AP is reported. About one-fourth of patients with AP, develop severe acute pancreatitis (SAP) which may lead to a life-threatening complications and mortality rate is reported up to 5% [1].